Literature DB >> 1727765

Prospective evaluation of immediate versus delayed refeeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage.

L Laine1, H Cohen, J Brodhead, D Cantor, F Garcia, M Mosquera.   

Abstract

The effects of immediate vs. delayed refeeding and the prognostic value of endoscopic findings in patients with major upper gastrointestinal hemorrhage were assessed in a prospective randomized study. Entry criteria were clinical evidence of major hemorrhage and endoscopic evidence of a Mallory-Weiss tear or an ulcer with a clean base, flat spot, or clot. Two hundred fifty-eight patients were randomly assigned to groups receiving a regular diet immediately or nothing by mouth for 36 hours, then clear liquids for 12 hours, and a regular diet thereafter. Outcomes in the immediate and delayed refeeding groups were comparable: rebleeding occurred in 4% vs. 5%; urgent intervention, 2% vs. 2%; and deaths, 1% vs. 1%, respectively. Rebleeding occurred in 2 (2%) of 96 patients with cleanbased ulcers, 5 (8%) of 65 with ulcers with spots, 3 (14%) of 21 with ulcers with clots (P = 0.05, 3 x 2 chi2 test), and 1 (2%) of 66 with Mallory-Weiss tears. It is concluded that the time of refeeding does not influence the hospital course of patients with a low risk of recurrent bleeding. Patients with clean-based ulcers or nonbleeding Mallory-Weiss tears may be refed and discharged home immediately after stabilization.

Entities:  

Mesh:

Year:  1992        PMID: 1727765     DOI: 10.1016/0016-5085(92)91816-m

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Outcome of non-variceal acute upper gastrointestinal bleeding in relation to the time of endoscopy and the experience of the endoscopist: a two-year survey.

Authors:  Fabrizio Parente; Andrea Anderloni; Stefano Bargiggia; Venerina Imbesi; Emilio Trabucchi; Cinzia Baratti; Silvano Gallus; Gabriele Bianchi Porro
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 2.  Upper gastrointestinal bleeding risk scores: Who, when and why?

Authors:  Sara Monteiro; Tiago Cúrdia Gonçalves; Joana Magalhães; José Cotter
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

3.  Comparison of the Effectiveness of Interventional Endoscopy in Bleeding Peptic Ulcer Disease according to the Timing of Endoscopy.

Authors:  Hyun Seok Cho; Dong Soo Han; Sang Bong Ahn; Tae Jun Byun; Tae Yeob Kim; Chang Soo Eun; Yong Cheol Jeon; Joo Hyun Sohn
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

4.  Selective Outpatient Management of Upper Gastrointestinal Bleeding in the Elderly: Results from the SOME Bleeding Study.

Authors:  F Cebollero-Santamaria; J Smith; S Gioe; T Van Frank; R McCall; J Airhart; R Perrillo
Journal:  Ochsner J       Date:  1999-10

Review 5.  Gastric acid inhibition in the treatment of peptic ulcer hemorrhage.

Authors:  Kevin A Ghassemi; Thomas O G Kovacs; Dennis M Jensen
Journal:  Curr Gastroenterol Rep       Date:  2009-12

Review 6.  Current management of bleeding peptic ulcer. A review.

Authors:  M Z Panos; R P Walt
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

7.  Acute Nonvariceal Upper Gastrointestinal Hemorrhage.

Authors:  Grace H. Elta
Journal:  Curr Treat Options Gastroenterol       Date:  2002-04

8.  Predictors for the need for endoscopic therapy in patients with presumed acute upper gastrointestinal bleeding.

Authors:  Su Sun Kim; Kyung Up Kim; Sung Jun Kim; Seung In Seo; Hyoung Su Kim; Myoung Kuk Jang; Hak Yang Kim; Woon Geon Shin
Journal:  Korean J Intern Med       Date:  2017-12-15       Impact factor: 2.884

9.  Hydrogen peroxide improves the visibility of ulcer bases in acute non-variceal upper gastrointestinal bleeding: a single-center prospective study.

Authors:  Subbaramiah Sridhar; Sherman Chamberlain; Dharma Thiruvaiyaru; Sankara Sethuraman; Jigneshkumar Patel; Moonkyung Schubert; Francisco Cuartas-Hoyos; Robert Schade
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.